The long view

Introducing The Long View, a new editorial series from iDSocial on glaucoma and the decisions that shape a patient’s vision over decades, not visits. Three conversations, four surgeons: Leonard Seibold, MD, on the 24-month interim read from the VENICE trial and what it means that more than 80% of eyes were medication free at two years. Deborah Ristvedt, DO, on interventional glaucoma and the question every surgeon should ask about drops: are they really taking them? William Wiley, MD, and Camila Albo, MD, on where MIGS fits when you are training to be a cataract refractive surgeon. visit www.idsocial.com for more series content. This independent program was supported by New World Medical. #glaucoma #ophthalmology #MIGS #cataractsurgery #iDSocial #TheLongView